Cryo-Cell International, Inc.
Market Cap
$23.76M
P/E Ratio
-9.52
EPS
$-0.31
Dividend Yield
4.60%
52-Week Range
$2.87 — $6.79
Volume
10.36K
Avg Volume
13.21K
Beta
0.68
P/E (TTM)
-9.52
Forward P/E
—
PEG Ratio
0.03
P/S (TTM)
0.83
P/B (TTM)
-1.41
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
0.15%
ROA (TTM)
-0.04%
ROIC
—
Gross Margin
0.77%
Operating Margin
0.02%
Net Margin
—
Debt/Equity
-0.17
Current Ratio
0.59
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-1.05%
EPS Growth (5Y)
-0.59%
Sales Growth (3Y)
+0.03%
Sales Growth (5Y)
+0.00%
EPS Est (This Year)
$-0.42
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
$0.15
Payout Ratio
—
Frequency
—
Ex-Dividend Date
2025-05-21
Cash/Share
$0.41
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
8.06M
Float
4.20M
Free Float %
52.19%
RSI (14)
50.00
SMA 20
$3.40
SMA 50
$3.60
SMA 200
$4.36
ATR (14)
0.20
Volatility (Week)
0.01%
Volatility (Month)
0.01%
Pattern
—
1 Day
+0.89%
1 Week
-0.29%
1 Month
-4.23%
3 Months
-19.05%
6 Months
-31.31%
1 Year
—
YTD
-0.87%
All-Time High
$8.79
Sector
Healthcare
Industry
Medical - Care Facilities
Country
US
Exchange
NASDAQ
IPO Date
1994-04-04
Employees
82
CEO
David I. Portnoy
Index Membership
—
Website
https://www.cryo-cell.com
Cryo-Cell International, Inc. (CCEL) is a healthcare company in the medical - care facilities industry listed on the NASDAQ. With a market capitalization of $23.76M, a P/E ratio of -9.52, and a dividend yield of 4.60%, CCEL is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare CCEL against other stocks using dozens of fundamental and technical filters.
Cryo-Cell International, Inc. (CCEL) has a trailing twelve-month (TTM) P/E ratio of -9.52. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Cryo-Cell International, Inc. (CCEL) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Cryo-Cell International, Inc. (CCEL) has a market capitalization of $23.76 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Cryo-Cell International, Inc. (CCEL) has returned -0.87% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.